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Abstract
Background: Most antibiotic prescriptions for acute cough due to lower respiratory tract infections
(LRTI) in primary care are not warranted. Diagnostic uncertainty and patient expectations and worries are
major drivers of unnecessary antibiotic prescribing. A C-reactive protein (CRP) point of care test may help
GPs to better guide antibiotic treatment by ruling out pneumonia in cases of low test results. Alternatively,
enhanced communication skills training to help clinicians address patients' expectations and worries could
lead to a decrease in antibiotic prescribing, without compromising clinical recovery, while enhancing
patient enablement. The aim of this paper is to describe the design and methods of a study to assess two
interventions for improving LRTI management in general practice.
Methods/Design: This cluster randomised controlled, factorial trial will introduce two interventions in
general practice; point of care CRP testing and enhanced communication skills training for LRTI. Twenty
general practices with two participating GPs per practice will recruit 400 patients with LRTI during two
winter periods. Patients will be followed up for at least 28 days. The primary outcome measure is the
antibiotic prescribing rate. Secondary outcomes are clinical recovery, cost-effectiveness, use of other
diagnostic tests and medical services (including reconsultation), and patient enablement.
Discussion: This trial is the first cluster randomised trial to evaluate the influence of point of care CRP
testing in the hands of the general practitioner and enhanced communication skills, on the management of
LRTI in primary care. The pragmatic nature of the study, which leaves treatment decisions up to the
responsible clinicians, will enhance the applicability and generalisability of findings. The factorial design will
allow conclusion to be made about the value of CRP testing on its own, communication skills training on
its own, and the two combined. Evaluating a biomedical and communication based intervention ('hard' and
'soft' technologies) together in this way makes this trial unique in its field.
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Background
This article describes the design of a cluster randomised
clinical trial (RCT) evaluating the clinical efficacy and
cost-effectiveness of a point of care C-reactive protein
(CRP) test and enhanced communication skills in the
management of lower respiratory tract infections (LRTI)
in general practice.
About 80% of all antimicrobials are prescribed in primary
care, and up to 80% of these are for respiratory tract indi-
cations, including acute cough. Respiratory tract infec-
tions are by far the most common cause of cough in
primary care[1,2]. Broad spectrum antibiotics are often
prescribed for cough, including acute bronchitis[3,4], and
many of these prescriptions will benefit patients only
marginally if at all (Number Needed to Treat = 17)[5], and
may cause side effects (Number Needed to Harm = 33)[5].
Unnecessary prescribing, especially of broad spectrum
antibiotics, drives antimicrobial resistance, wastes money
and raises wrong expectations for patients. Microbial
resistance topped the list of priority intervention needs in
the World Health Organization report on Priority Medi-
cines. Although the Netherlands is one of the lowest anti-
biotic prescribing countries worldwide, unnecessary
prescribing for LRTI remains of great concern[6]. While
unnecessary prescribing is a highly complex phenome-
non, much of it relates to two factors, diagnostic uncer-
tainty and patients' expectations. Interventions therefore
should be aimed at clinicians to address these two factors.
Previous studies with interventions aimed at general prac-
titioners have resulted in less antibiotic prescribing[7,8].
Diagnostic uncertainty and C-Reactive protein
LRTI represents a source of considerable diagnostic uncer-
tainty for clinicians. Only a small number of patients with
signs and symptoms of LRTI have pneumonia. Differenti-
ating pneumonia from acute bronchitis on clinical
grounds is often impossible and so clinicians frequently
prescribe antibiotics empirically. However, as acute bron-
chitis is generally self-limiting, and benefits do not gener-
ally outweigh possible side effects from antibiotic
treatment[5,9], rapid diagnostic tools to determine which
patients will benefit from antibiotic treatment are
urgently needed[10].
C-reactive protein is a marker of an acute inflammatory
response. Several studies have indicated that CRP is prob-
ably the most feasible and accurate investigation to differ-
entiate pneumonia from acute bronchitis in patients with
LRTI in general practice [11-14]. We demonstrated in an
earlier diagnostic study that for patients with a CRP less
than 20 mg/l and who had no more than 1 of the 3 clini-
cal predictors of pneumonia (dry cough, fever, diarrhoea),
the absolute risk of pneumonia was reduced from 13% to
less than 3%[11]. In daily practice a CRP value will only
be useful when available during the initial consultation.
CRP is available as a feasible point of care test for primary
care and the test result can be available within three min-
utes. A low CRP test result is especially useful for reassur-
ing both the doctor and the patient that further diagnostic
testing and antibiotic treatment are not necessary. CRP
tests can be done quickly, cheaply and with good reliabil-
ity in everyday general practice using a finger prick blood
sample[15]. In Scandinavia, point of care CRP testing is
part of the routine evaluation of patients with LRTI in gen-
eral practice, and its use has proved cost-effective[16,17].
In other countries including the Netherlands, however,
GPs are still relatively unfamiliar with point of care CRP
testing. The widespread introduction of point of care CRP
testing in the Scandinavian countries was not accompa-
nied by appropriate training for clinicians. This has led to
an overuse of CRP testing in often mild respiratory tract
infections. Slightly elevated CRP levels were too often fol-
lowed by an unnecessary antibiotic course[18]. Therefore,
thorough training in use and interpretation of test results
is needed for a fair chance of success. This should include
information about the diagnostic value of the test in addi-
tion to a focus on the fact that pneumonia can be excluded
by a low test result.
Patient expectations and enhanced communication within 
the consultation
Apart from diagnostic uncertainty, a range of other, 'non
medical' influences come to bear on the decision to pre-
scribe antibiotics[19]. Perceived patient pressure for an
antibiotic, patient expectations and satisfaction are major
factors influencing the decision whether to prescribe anti-
biotics [20-25]. Therefore, GPs need adequate communi-
cation skills to efficiently explain the pros and cons of
antibiotic treatment, natural course and when to re-con-
sult for this condition. Training GPs in enhanced consul-
tations may therefore lead to easier and more acceptable
non-antibiotic management[26]. Clinicians' communica-
tion skills in managing common infections are often sub-
optimal[27,28]. In one of our studies, for example, carers'
views/expectations on antibiotic treatment were elicited
in only one of 39 audio taped consultations for children
with respiratory tract infections[28]. Many GPs therefore
do not routinely use optimal communication skills to effi-
ciently implement a non-antibiotic management strategy
that patients would find acceptable and is time efficient in
time pressured consultations[29]. Although GPs perceive
high patient expectations for antibiotics, evidence sug-
gests that GPs are not good at estimating which patients
expect antibiotics. Patient satisfaction is determined more
by the quality of explanation and physical examination
than whether or not they receive a prescription for an anti-
biotic[20,30]. Rollnick et al. developed an innovative
communication skills training method which proved to
be practical and acceptable to experienced clinicians[26].BMC Family Practice 2007, 8:15 http://www.biomedcentral.com/1471-2296/8/15
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With everyday clinical experience in the foreground and
communication skills in the background this context-
bound method proved successful in sore throat consulta-
tions and was well received by GPs[31]. We have shown
that training clinicians using these methods was associ-
ated with changes in the behavior of clinicians and
patients in consultations for common infections. In an
interrupted time series pilot study, before training in our
enhanced consultation skills, GPs in 10 consultations elic-
ited patients concerns on two occasions and empathized
three times in total[31]. No evidence was found of elicit-
ing expectations of the consultation in general, or about
antibiotics. After training, the same clinicians elicited
patients concerns in 14 out of 15 consultations, elicited
general expectations 8 times, elicited expectations about
antibiotics in all 15 consultations, and empathized a total
of 38 times. Before clinician training, patients expressed
their expectations only once in 10 consultations and
asked questions a total of 12 times. After clinician train-
ing, patients expressed expectations in 14 out of 15 con-
sultations and asked questions a total of 33 times.
Although the importance of studying an intervention like
this in a large trial is obvious[32], as far as we know a full
cost-effectiveness analysis has never been performed, to
evaluate the efficacy of any intervention to improve health
care providers' behaviour regarding antibiotics prescrib-
ing.
Opportunities in LRTI
These studies on the potential for CRP and enhanced
communication skills indicate that these interventions,
either separately or combined, are able to have a positive
effect on the prevention of misuse of antibiotics in LRTI.
No point of care test has been evaluated together with
context-bound training in enhanced communication
skills.
Effective management of LRTI, we hypothesize, will
involve a point of care test that performs well in primary
care. It will also involve providing clinicians with the skills
to efficiently and effectively communicate about the con-
dition, its duration and implications to patients in a way
that might make them accept a potential non-antibiotic
management and facilitate patient enablement. However,
some may argue that one of these interventions alone or
indeed both together is required to enhance care. The fac-
torial design of this study allows us to answer these ques-
tions.
Research questions and outcome measures
This study will investigate the following research ques-
tions:
To what extent does the introduction of the C-Reactive Protein
(CRP) point of care test and enhanced communication skills for
managing LRTI in general practice, either separately or com-
bined, have effect on:
Primary outcome measure
1. Immediate antibiotic prescribing rates
Secondary outcome measures
1. Clinical recovery and return to usual activities
2. Cost-effectiveness of point of care CRP and communi-
cation training
3. Patient enablement, satisfaction and future consulting
intention
4. Diagnostic testing other than point of care CRP
5. Use of health services, including re-consultation
6. Subsequent antibiotic prescribing rates within 28 days
of the initial consultation
Ethical approval
The Ethics Committee of Catharina Hospital in Eind-
hoven, the Netherlands, approved the study protocol
under number M05-1529, in compliance with the Hel-
sinki Declaration.
Methods/Design
This study is an open randomised controlled trial in gen-
eral practice with randomisation at the practice level. The
practices will be allocated to one of four groups (table 1):
1. Access to and training in point of care CRP
Table 1: Intervention allocation
Communication skills training
+-
C-reactive protein point of 
care test
+ 5 practices (10 GPs) 5 practices (10 GPs)
100 patients 100 patients
- 5 practices (10 GPs) 5 practices (10 GPs)
100 patients 100 patientsBMC Family Practice 2007, 8:15 http://www.biomedcentral.com/1471-2296/8/15
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Study flow chart Figure 1
Study flow chart.
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2. Context-bound training in enhanced communication
skills for acute cough
3. Access to and training in the use of point of care CRP
plus context-bound training in enhanced communication
skills for acute cough
4. Usual care.
The GPs in groups 1 and 3 will be trained to use and inter-
pret point of care CRP and those in 2 and 3 in enhanced
communication with patients.
Randomisation
A cluster randomised design has been chosen to avoid
contamination. In order to allow assessment of the effects
of each individual intervention and of combinations of
interventions, compared with a control group, a factorial
design for randomisation by practice will be used. Two
randomisation procedures will be undertaken, one to cre-
ate two groups for CRP/no CRP and a second for commu-
nication skills training/No communication skills training.
The process will be stratified by the classification of the
practices as above/below average for their ability to recruit
patients (total number of practitioner clinics per practice
per week). This will ensure a balance in recruitment
potential between the two arms. Random permuted
blocks of four will be generated for each randomization
process. This will create two groups of 10 practices and
balance at the margins for the stratification variable.
Sample size calculation
In order to detect a reduction in antibiotic prescribing
from 80% to 60%, with 80% power at a 5% significance
level, an individually randomised study would require
175 patients. If we randomise 20 practices with an intra-
cluster correlation coefficient (icc) of 0.06 this increases to
350 patients. In order to allow for a 90% follow-up rate
for the primary outcome measure of antibiotic prescribing
we intend to recruit 400 patients (20 per practice and 100
in each cell). We have previously demonstrated that 40
GPs can recruit over 400 patients suspected of having a
LRTI in two winter seasons[11].
General practices
A total of 20 general practices will be recruited, with a
fixed number of two GPs per practice participating in the
study. The practices are located in the South-eastern part
of the province of Noord-Brabant in the Netherlands. This
region compromises both urban and rural areas.
Recruited practices will be geographically spread through-
out this region.
Patients
The GPs will approach sequential eligible adult patients
during regular consultation hours. Patients are eligible if
they present in general practice with an acute cough, last-
ing no more than 4 weeks, considered to be caused by
LRTI according to the GP. In addition, the patient needs to
have at least one focal and one systemic sign/symp-
tom[33] (Figure 1). Children will not eligible, since the
diagnostic value of CRP has not been investigated for LRTI
in children, consultations with children and their parents
will be different with respect to communication styles and
strategies, and diagnostic and prognostic factors are not
automatically applicable in infants. Exclusion criteria are
described in figure 1.
CRP point of care test
20 GPs will have a CRP test device in their practice. CRP
analysis will be carried out during the consultation. The
NycoCard® II Reader, product of Axis-Shield, will be used,
in accordance with the manufacturer's instructions. The
test system is based on an immunometric principle and
consists of 1) a liquid for sample dilution and lysis of
cells, 2) a test card with CRP-specific monoclonal anti-
bodies coated to a membrane, 3) a conjugate solution
with monoclonal antibodies coupled to ultra small gold
particles and 4) a washing solution. One single drop of
blood from a finger prick is needed to perform the test. A
capillary collects 5 μl blood which is diluted in the 0,4 ml
dilution liquid. 50 μl of this diluted sample is applied to
the test well of the device. When the sample flows through
the antibody-coated membrane, C-reactive proteins are
forced to react and bind to the antibodies on the mem-
brane. CRP trapped on the membrane will bind the anti-
body gold conjugate. Unbound conjugate is removed by
one drop of washing solution. In the presence of patho-
logical levels of CRP in the sample, the membrane appears
red-brown with color intensity proportionally to the CRP
concentration. The color intensity is measured quantita-
tively with the color densitometer NycoCard® Reader II.
The measuring range for whole blood samples is 8 to 250
mg/l. In the measuring range the test response is directly
proportional to the concentration of CRP in the sample.
For internal quality a control positive will be measured to
confirm the efficacy and correct performance of the test.
The control liquid is supplied with every test kit and will
be run after opening of a new kit, which is once in every
24 regular tests. CRP measurements with Nycocard® have
proven to be valid and robust in general practice[34]. The
result will be available within three minutes. This means
that GPs can use the test result within the consultation.
The 20 GPs who are allocated to the CRP intervention will
be given guidance about the interpretation of CRP results.
This information will include a comprehensive summary
of the literature on LRTI and the role of CRP. We will not
instruct the GPs in a prescription style fashion. Focus willBMC Family Practice 2007, 8:15 http://www.biomedcentral.com/1471-2296/8/15
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be on informing them on the additional diagnostic value
of CRP in ruling out pneumonia. GPs will decide on man-
agement including possible antibiotic treatment in every
patient. CRP may complement their clinical findings and
help in deciding upon diagnosis and treatment. The desk
reminder for CRP interpretation in LRTI can be seen in fig-
ure 2. Practice assistants will be trained to use the Nyco-
Card® II Reader by the Dutch distributor who has over 10
years of training experience. GPs and assistants will be
able to consult a 24-hour helpdesk for technical assist-
ance. Questions on interpretive issues can be submitted to
the research team. For specific test handling questions, we
will also create a direct telephone number connecting the
assistant with a clinic where assistants have extensive
experience with handling point of care CRP testing. Once
the CRP devices have been installed and training sessions
have been performed, practices will get a 8-week run-in
period before inclusion starts for familiarisation with the
device and interpretation of the results.
Communication training
The communication training is based upon a patient-cen-
tred strategy to achieve shared decisions about investiga-
tion and treatment of acute infections. The intervention is
based on the elicit-provide-elicit framework, which has its
background in motivational interviewing and which has
been refined for use in primary care[26]. The context-
bound training for acquiring these communicating skills
involves one two-hour training seminar at a central loca-
tion, preceded and followed by consulting with simulated
patients in routine surgeries. It involves the following spe-
cific elements:
1. Simulated patient in clinical encounter, part 1
Two experienced simulated patients will be trained to
simulate a patient with acute bronchitis persisting for two
weeks. The patient is worried about the duration of the
cough and has distinct sleeping problems and impaired
daily activities due to the cough. The simulated patients
will consult with participating GPs at their own surgeries
during regular surgery hours. The simulated patients will
carry an audiotape device to record the conversation,
which will be transcribed by trained typists.
2. Seminar on shared decision making
Within one week after their first simulated patient consul-
tation, all 20 GPs will gather for a training seminar on
enhanced communication skills. Three seminars will be
held, with 5–8 GPs participating per session. All session
will have the same format and content (see below). An
experienced moderator from the Department of Voca-
tional Training in General Practice will lead the seminar.
The GPs will be encouraged to actively participate in all
sections of the training. After a brief introduction, the GPs
will receive transcripts of their first simulated patient con-
tact. They will be asked to read their own transcript and
make notes. Subsequently, the moderator will invite them
to share their reactions to their transcripts and to identify
noteworthy aspects. These can be of any kind; structure,
vocabulary or occurring difficulties in management. The
focus will be on the acute cough patient. This will be fol-
lowed by a short presentation on current views and
insights on LRTI. The contrast between evidence from
research and figures from daily practice will be high-
lighted to stress the importance of enhancing LRTI consul-
tations. GPs will be given the opportunity to contribute
their own suggestions for enhancing LRTI consultations.
The elicit-provide-elicit framework will be outlined[26],
where the GP first elicits what the patient knows about his
condition and what the patient's main worries and expec-
tations are. Crucially, the GP actively asks how the patient
feels about antibiotics. This serves two purposes; firstly, to
provide the GP with the patient's expectation and hope
for antimicrobial treatment (making patients' expecta-
tions explicit). Secondly, it enables the GP to openly dis-
cuss his opinion on antibiotic treatment, mentioning the
balance of possible benefits and harms of antibiotic treat-
ment. Secondly, the GP provides information relevant to
the patients' individual understanding and interest. This
includes findings from the medical history and physical
examination. Then the GP elicits the patients' interpreta-
tion about what has been said and done, and discusses
implications for help seeking behaviour. Specific alarm
symptoms should be mentioned to provide exact infor-
mation to the patient about when to re-consult. All com-
munication is based on an assessment of patients'
information needs, thus achieving efficiency by targeting
information to individual needs. Practice-based examples
will be presented in video clips. Finally, GPs will be asked
to attempt to identify the specific aspects, which need
most attention during their consultations. Supported by a
desk reminder (Figure 2) we will ask the GPs to imple-
ment the specific steps of the communication training in
their routine acute cough consultations.
3. Simulated patient in clinical encounter, part 2
The GPs will get the opportunity to use the enhanced
communication skills in daily practice during eight weeks
before inclusion start. The two simulated patients will
now switch practices, visiting the practices they did not
visit, while playing a similar acute bronchitis role. Trained
typists will once again transcribe the audio-recorded con-
sultations. These transcripts will be copied and made
anonymous, after which they are sent to a colleague par-
ticipating in the study. This GP will be asked to write com-
ments on the transcript based on the enhanced
communication method and to add possible suggestions
for improvement. The project team will edit or add com-
ments if needed. Finally, the peer-reviewed transcript will
be returned to the GP who conducted the consultation.BMC Family Practice 2007, 8:15 http://www.biomedcentral.com/1471-2296/8/15
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Desk reminders for GPs allocated to the CRP and/or communication skills interventions Figure 2
Desk reminders for GPs allocated to the CRP and/or communication skills interventions.
IMPAC
3T
LOWER RESPIRATORY TRACT INFECTIONS
C-Reactive Protein test: 
x Rule out pneumonia 
x Combine clinical findings with CRP 
CRP < 20 
Pneumonia extremely unlikely 
CRP 20 – 50
Pneumonia very unlikely
CRP 50 – 100 
Clear infection 
Most likely acute bronchitis   
Possibly pneumonia  
Combination clinical findings & CRP very important
CRP > 100 
Severe infection 
Pneumonia more likely 
IMPAC
3T
LOWER RESPIRATORY TRACT INFECTIONS
Communication items: 
Elicit worries / expectations
Actively ask opinion on antibiotics 
Essential information: 
Duration cough > 4 weeks 
Acute bronchitis is self-limiting (regardless of virus/bacteria) 
Body will fight it, but it needs time 
Antibiotica: benifits = harms 
Eat & drink well, limit activities
Summarise and elicit understanding of information 
Alarm symptoms
When to reconsult  BMC Family Practice 2007, 8:15 http://www.biomedcentral.com/1471-2296/8/15
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Commenting on a colleague's transcript may promote
GPs' critical reflection on their own peer-reviewed tran-
scripts. Thus, participating GPs will benefit from reading
and feeding on a colleague's transcript and from reflection
on their own transcript.
Data collection
Sequential elegible patients will be asked by their GP to
participate. During this consultation, the GP will take
written consent and note the inclusion criteria on the trial
inclusion form. The practice nurse will give each partici-
pant a simple self-complete symptom diary after the con-
sultation. After general questions on cough and the
consultation, patients will be asked each day to complete
a 6 item scale, with responses to statements ranging from
0 to 6. A total symptom score will be derived from this
scale. Items relate to coughing, phlegm, shortness of
breath, sleep disturbance, impairment of normal daily
activities, and generally feeling unwell. This symptom
diary has previously been used in a large LRTI study[35].
Patients will then be followed-up for 28 days, or if still
unwell, until recovered with a maximum follow up of ten
weeks. Furthermore, weekly questions will record time off
work, medication use and re-consultation. The recruiting
GP will fax the informed consent form and inclusion form
to the research team in Maastricht on the day of inclusion.
The clinical effectiveness analysis will be based on diary
responses. A single Likert type scale response item will
assess satisfaction with the consultation. Patient enable-
ment will be measured using the Patient Enablement
Instrument [36] translated into Dutch. Concurrent valida-
tion will be undertaken. In addition, the research team
will retrieve data on diagnosis, antibiotic prescription, re-
consultation, diagnostic testing other than CRP and
related medical consumption from participating patients'
electronic medical records over 28 days follow-up. A soci-
etal perspective will be used for the economic evaluation.
Thus, for all four groups, in addition to costs to the health
care system, we will take into account medical costs borne
by patients and production costs due to illness related
absence from work. Use of health care facilities will be
prospectively recorded in a standardised way including all
re-consultations, telephone consultations, out-of-hours
consultations, and hospital admissions, (repeat) prescrip-
tion of antibiotics (type, dosage, duration) and additional
diagnostic tests, including bacteriological culture and X-
ray. A patient diary will be the basis for assessing actual
medication use, other medical costs to the patient, and
absence from work[37].
The research team will retain transcripts of simulated
patient consultations. Transcripts before the seminar will
be compared with those afterwards for evidence of acqui-
sition of the enhanced communication skills (compe-
tence).
Patient follow-up
The respondent burden will be kept to a minimum. The
research team will contact patients by telephone within
four days to offer further information about study partici-
pation and to iron out eventual problems concerning
study materials. Reminders to complete study documents
will be sent by post to patients after 14 days, and patients
will receive a reminder postcard at the end of the follow
up period.
Analysis
Statistical analyses will be performed with the aid of the
SPSS and STATA statistical packages. The primary analysis
will be intention to treat and will compare the marginal
effects of the two interventions on antibiotic prescribing
at the index consultation and incorporate an interaction
effect. The interaction term will be included to test for a
synergistic or antagonistic relationship between the two
interventions. This will be tested using a three level logis-
tic regression model to account for variation at the prac-
tice/GP/patient. If there is no indication of random effects
at a GP level, then this will be reduced to a two level
model with GP seen acting as a patient level covariate.
A four level linear regression model will be fitted to the
symptom scores (logged) to account for practice, GP,
patient and repeated assessments over time. The correla-
tion between repeated assessments within individual
patients will be modelled to allow for greater correlation
between assessments, which are closer in time. The effect
of interventions would be seen in the comparison of the
slopes of symptom scores over time in the groups, i.e. hav-
ing faster (or slower) recovery rates[38]. Sensitivity analy-
ses on the symptom scores will be undertaken to assess
the impact of loss to follow-up by either interpolating
from available data using the estimated slope of symp-
toms from the model or using last value carried forward.
The later is unlikely to arise in practice for an acute infec-
tion, however provides a useful extreme bound in which
to interpret results.
Secondary outcomes (satisfaction, enablement, re-consul-
tation and other investigations) will be compared
between the two groups using three level regression mod-
els (linear and logistic where appropriate). No formal sub-
group analyses are planned. However, exploratory analy-
ses will investigate the influence of patient and practi-
tioner demographics on outcomes. The statistical
uncertainty regarding the cost-effectiveness of the differ-
ent strategies will be assessed using non-parametric boot-
strap resampling techniques and result in estimates of net
monetary benefit values. For the groups of GPs trained in
enhanced communication skills and/or CRP testing, the
cost analysis will be extended beyond patient level data.
Training will lead to additional costs (organising and giv-BMC Family Practice 2007, 8:15 http://www.biomedcentral.com/1471-2296/8/15
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ing the training and GPs' time investment) which will be
included in the analysis[39]. Such overhead costs are basi-
cally one-time costs and can therefore be regarded as fixed
costs that will be measured at the level of the trained GPs
and attributed to an individual patient, which will be
done on the basis of a division calculation as proposed by
Mason et al (2001)[40]. The trial will be reported follow-
ing CONSORT guidelines, extended for cluster ran-
domised trials[41].
Discussion
This trial will be the first randomised controlled trial to
evaluate the use of point of care CRP testing and enhanced
communication skills training, on the management of
acute cough due to LRTI in primary care. Both are promis-
ing interventions in reducing unnecessary antibiotic pre-
scribing. A systematic evaluation in daily general practice
is required to assess effectiveness. Our inclusion criteria
are quite broad as a reflection of daily practice. LRTI is
such a commonly seen illness among the full range of
patients in primary care that we think the inclusion crite-
ria should enable us to investigate all these patients. Pri-
mary inclusion criterion is the GP's suspicion of LRTI
being the primary cause of the acute cough episode. GPs
are daily facing difficulty in deciding upon management
for these patients. The pragmatic approach of this trial
leaves them very close to daily practice when considering
recruiting the patient for this study. We did however
define a group of focal and a group of systemic signs and
symptoms in the inclusion criteria, which indicate that
this patient has signs and symptoms of an infection of the
lower respiratory tract.
A low CRP test result, expected to occur in at least half of
these patients with LRTI, will be reassuring for both the
GP and the patient that the illness is mild and most prob-
ably self-limiting. On the other end of the spectrum, very
high test results will help the GP in considering antibiotic
treatment or referral to a hospital. To achieve this GPs
must be aware of the usefulness of the test and they
should be able to properly interpret results. These are cru-
cial conditions for a positive effect of the CRP interven-
tion. If GPs are not aware of the value of the test, other
important influences such as time pressure and patients'
expectations may dilute any possible effect on antibiotic
prescribing. If GPs are able to build the communication
skills, which take the latter influences into account, into
their routine consultations, long term competence and
performance have to be monitored, since maintenance of
acquired communication skills is difficult. So even when
GPs understand the theory of the test and the principle of
the enhanced communication, the question remains
whether they will use it to adjust the management of LRTI
patients.
We chose a factorial design, as it will enable us to effi-
ciently investigate the interventions by including all par-
ticipants in both analyses. Furthermore it will give us the
opportunity to consider both the individual effects of
both interventions and the benefits of receiving both
interventions together. Factorials trials do require special
considerations at the analysis stage. Interaction between
the interventions needs to be investigated, since this can
have effect on the power of the study[42].
In this trial both interventions are targeted at the GPs with
impact on patient outcomes. Randomisation at practice
level has been chosen in this trial, because there is less risk
of contamination by GPs concurrently managing usual
care patients, while other GPs manage their patients under
the experimental regimen in the same practice. However,
since patients yet have to be recruited after randomisation
post-randomisation recruitment bias deserves special
attention. One may expect that practices not receiving a
desired intervention may gradually loose enthusiasm to
recruit. As a strategem to prevent this, those practices allo-
cated to the usual care arm, as well as those allocated to
one of the arms to which only one intervention will be
allocated, will be informed that they will receive a CRP
device and/or the communication training after the study
period. Recruitment rates across the four groups have to
be monitored and baseline characteristics will be
described to ensure comparability. Because of the small
number of practices involved, randomisation will be
restricted carefully with regard to recruitment ability. With
a small number of clusters and a large number of patients
this trial may be difficult to analyse and risk of loss of
power exists if one practice should drop out. In cluster
randomised trials the outcome for each patient cannot be
assumed to be independent of that of any other patient
since the patients within one cluster (practice) are more
likely to have similar outcomes. Therefore multi-level
analysis will be performed.
Prediction of sample size in cluster randomised trials is
difficult given the fact that not only the expected effect size
has to be estimated, but also the anticipated cluster size
and intra-cluster correlation coefficient[43]. Despite these
limitations analysis on both cluster level as well as indi-
vidual level will provide us the best information on the
outcome of this study[44]. Results will be reported with
full transparency with regard to the factorial and cluster
design[41,42].
The study will allow us to get more insight into the natural
course of this common but still under-researched illness.
The long follow-up of 28 days and the daily patients' eval-
uation of number and extent of their symptoms will pro-
vide crucial information on natural course, burden and
impact on daily activities.BMC Family Practice 2007, 8:15 http://www.biomedcentral.com/1471-2296/8/15
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To our knowledge, both from the point of view of inter-
ventions and study design, this is a unique study. It will be
the first to evaluate complex interventions separately and
combined, that focus on the biomedical evaluation of the
illness and patient centered communication. The prag-
matic nature of the study, which leaves treatment deci-
sions up to the responsible clinicians, will enhance the
applicability and generalisability of findings. If these
interventions decrease antibiotic prescribing and enhance
patient satisfaction with favourable clinical outcomes,
they could be used to enhance the quality of a large
number of consultations in primary care, both for com-
mon infections and for other conditions. A full cost-effec-
tiveness analysis to evaluate the efficiency of the
interventions is needed in this regard as well and will
therefore be performed. This has never been done before
for an intervention to improve health care providers' com-
munication regarding antibiotics prescribing.
If these complex interventions are shown to be effective
and cost-effective, they may be refined as a result of the
research and we will promote uptake in everyday care.
Abbreviations
GP General practitioner
LRTI Lower respiratory tract infection
CRP C-reactive protein
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